共 285 条
[11]
Salem JE(2017)Primary, adaptive, and acquired resistance to cancer immunotherapy Cell 168 707-34
[12]
Manouchehri A(2018)Mechanisms of resistance to PD-1 and PD-L1 blockade Cancer J 24 47-868
[13]
Moey M(2021)Cardiotoxicity associated with immune checkpoint inhibitor therapy: a meta-analysis Eur J Heart Fail 23 1739-2194
[14]
Mahmood SS(2016)Fulminant myocarditis with combination immune checkpoint blockade N Engl J Med 375 1749-228
[15]
Fradley MG(2011)PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice J Exp Med 208 395-2051
[16]
Cohen JV(2012)Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape Cancer Res 72 917-903
[17]
Johnson DB(2022)Relatlimab and nivolumab versus nivolumab in untreated advanced melanoma N Engl J Med 386 24-4409
[18]
Sullivan RJ(2021)Pericardial disease in patients treated with immune checkpoint inhibitors J Immunother Cancer 9 e002771-520
[19]
Menzies AM(2022)Cardiac toxicity associated with immune checkpoint inhibitors: a systematic review Int J Mol Sci 23 10948-1776
[20]
Yousif LI(2020)Myocardial vasculitis associated with the immune checkpoint inhibitor pembrolizumab JACC Case Rep 2 1937-12